{
    "nct_id": "NCT04518046",
    "official_title": "A Phase 1/1b Study of Sitravatinib in Combination With Nivolumab and Ipilimumab in Patients With Advanced or Metastatic Clear-Cell Renal Cell Carcinoma or Other Solid Malignancies",
    "inclusion_criteria": "* Confirmed diagnosis of Clear-Cell Renal Cell Carcinoma (for initial cohorts under consideration)\n* No prior treatment with systemic therapy (for initial cohorts under consideration)\n* Adequate bone marrow and organ function\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Known or suspected presence of other cancer\n* Brain metastases (for initial cohorts under consideration)\n* Carcinomatous meningitis\n* Immunocompromising conditions\n* Impaired heart function\n* Active or prior documented autoimmune disease",
    "miscellaneous_criteria": ""
}